BURLINGTON, N.C., July 3, 2023 /PRNewswire/ -- Labcorp (LH) (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that it has completed the spin-off of ...

NEW YORK CITY, NY / ACCESS Newswire / July 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ:FTRE) and ...

The lawsuit was filed on behalf of investors who acquired Fortrea securities from July 3, 2023, through February 28, 2025 (“the Class Period”). Investors have until August 1, 2025, to apply to the ...

Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities within the organization in connection with our LaunchPad initiatives ...

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ:FTRE) and ...

Analysts have set 12-month price targets for Fortrea Holdings, revealing an average target of $15.5, a high estimate of $25.00, and a low estimate of $9.00. This upward trend is evident, with the ...

Laboratory Corporation of America Holdings LH, or Labcorp, is well-poised to grow in the coming quarters, backed by the continued strength of Central Labs, which is driving the success of the ...

Fortrea is a global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device ...

Investment management company Curreen Capital released its second-quarter 2025 Investor letter. A copy of the letter can be downloaded here. In the second quarter, Curreen Capital was up 14.07% vs. 10 ...

In the last three months, 6 analysts have published ratings on Fortrea Holdings (NASDAQ:FTRE), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...